X4 Pharmaceuticals (XFOR) President John Volpone Sells 24,576 Shares

What Happened John Volpone, President of X4 Pharmaceuticals (XFOR), sold 24,576 shares of XFOR common stock in an open-market/private sale on August 12, 2026. The filing reports a weighted-average sale price of $4.44 per share (range $4.33–$4.55), for aggregate proceeds of approximately $109,228. The filing notes the sale was to cover personal income tax obligations arising upon settlement of a restricted stock unit (RSU) award.

Key Details

• Transaction date: 2026-08-12; filing date: 2026-08-13 (filed promptly, not late).
• Transaction type/code: Sale (S).
• Shares sold: 24,576; weighted-average price: $4.44; price range: $4.33–$4.55.
• Proceeds: ~$109,228.
• Footnote F1: Sale to cover personal income tax on RSU settlement (tax withholding).
• Footnote F2: Price is a weighted average over multiple trades; full breakdown available upon request.
• Footnote F3: The filing notes 193,254 shares reported represent restricted stock units.
• Shares owned after transaction: not specified in the provided summary.

Context This was a sale tied to tax withholding for RSU settlement, a routine administrative transaction rather than an obvious directional bet on the stock. For retail investors, purchases generally carry clearer signals than tax-related or withholding sales. The filing shows multiple trade prices within a narrow range and the reporting person offers to provide per-trade details if requested.